ST3 β-Gal α-2,3-Sialyltransferase 5 | MedChemExpress (MCE)
ST3 β-Gal α-2,3-Sialyltransferase 5 (ST3GAL5) is a glycosphingolipid (GSL) biosynthetic enzyme that can inhibit TGF-β-induced epithelial-mesenchymal transition (EMT), invasion, and metastasis both in vivo and in vitro. ST3 β-Gal α-2,3-Sialyltransferase 5 can be used in cancer research[1].
| Trivial name | ST3 β-Gal α-2,3-Sialyltransferase 5 |
| Catalog Number | HY-E70299 |
| Alternative Name(s) | ST3GAL5 |
| Research Area | Cancer |
| Purity | ≥98.0% |
| SMILES | [ST3 b-Gal a-2,3-Sialyltransferase 5] |
| Size | 100 µ g |
| Supplier Page | https://www.medchemexpress.com/st3-β-gal-α-2-3-sialyltransferase-5.html |